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During the past decade the increase of antibiotic resistance
in Enterobacteriaceae has become a major concern world-
wide. Although beta-lactams have been widely used as the
mainstay of treatment for severe infections due to these bac-
teria, with carbapenems often representing last-resource
drugs, carbapenem resistance due to acquired carbapenemas-
es has emerged and spread worldwide since the early 2000s,
being even more worrisome for public health because these
bacteria are a common source of hospital-acquired infec-
tions. Carbapenemases have been now studied in depth, and
widely differ from one another, including enzymes from class
B (metallo-beta-lactamases, MBLs), class A and class D (ser-
ine carbapenemases) [1]. The most prevalent carbapenemase
so far in Enterobacteriaceae is the KPC-type class-A carbape-
nemase, which has been found in Klebsiella pneumonia, espe-
cially in the United States, Asia, the United Kingdom, Israel
and southern Europe [2]. Interestingly, acquired carbapene-
mases have been mainly restricted to geographical areas and
to speciﬁc bacterial species, and outbreaks as well as spread
in other countries have been often associated with imported
cases from countries where the bacteria are endemic. Popu-
lation mobility is known to be a main factor in globalization
and spreading of antimicrobial drug-resistant organisms [3].
For example, the emergence of KPC-producing Enterobacteri-
aceae in the United States in 2001 [2] could be later associ-
ated with the emergence of travel-related outbreaks in other
countries [1,4].
The New Delhi metallo-beta-lactamase (NDM-1) is a
novel type of MBL named after the city of origin, which has
been recently criticized, following a common practice with
transferable MBLs since VIM-1 was named after Verona, Italy
[5]. NDM-1 was ﬁrst reported in 2009 in a Swedish patient
of Indian origin, who travelled to New Delhi and acquired a
urinary tract infection due to a carbapenem-resistant K. pneu-
moniae strain resistant to all antibiotics tested except colistin
[6]. Faecal samples collected from this patient during his stay
at the nursing home yielded an NDM-1 positive E. coli as well
[6]. The NDM-1 encoding gene is located on different large
plasmids (a 180-kb plasmid for K. pneumoniae and a 140-kb
plasmid for E. coli) that are easily transferable to susceptible
E. coli J53 at a high frequency [6]. These plasmids also har-
bour genes conferring resistance to almost all antibiotics,
thus making their rapid dissemination in clinically relevant
bacteria a serious threat for therapy. Following this ﬁrst
case, sporadic cases of infection due to NDM-1 positive bac-
teria have been detected, including an E. coli from blood cul-
tures of a patient of Indian origin in the United Kingdom [7],
three cases of Enterobacteriaceae isolates (one E. coli, one
K. pneumoniae and one E. cloacae) in the United States from
patients who received care in India [8], and three cases of
Acinetobacter baumannii from New Delhi [9]. In the August
issue of the journal The Lancet: Infectious Diseases, a multina-
tional team reported the emergence and spread of 180 cases
of patients infected by bacteria carrying the NDM-1, includ-
ing 37 cases in the United Kingdom and 143 cases in various
sites in Pakistan and India, thus suggesting a widespread
dissemination [10]. Among these bacteria many different
Enterobacteriaceae species were identiﬁed, including K. pneu-
monia, E. coli, E. cloacae, Proteus spp., Citrobacter freundii,
K. oxytoca, M. morganii and Providencia spp. Most isolates
remained susceptible to colistin and tigecycline, except those
Enterobacteriaceae endowed with a natural resistance to
these compounds such as M. morganii, Proteus spp. and Provi-
dencia spp. Most plasmids detected in these bacteria were
easily transferable and capable of wide rearrangement, sug-
gesting a widespread transmission and plasticity among bacte-
rial populations. Interestingly, among the 25 patients
detected in the UK, 17 patients had travelled to India or
Pakistan within 1 year and 14 had been hospitalized in these
countries showing a worldwide dissemination of a new
‘superbug’ from a local source in Asia [10]. Indeed, since August
2010, spreading and dissemination has occurred, with several
cases being reported by national and international media from
other countries in all continents, including the United States
and Canada, Europe (Sweden, the United Kingdom, Austria,
Belgium, France, Netherlands and Germany), Japan, Africa,
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Oman and Australia [11–14] (Fig. 1). A K. pneumoniae NDM-
1 positive strain has been recently isolated from a patient
repatriated in Marseille, France, in April 2010, after an
accident in New Delhi (personal communication). To date
there is only one reported death attributed to an infection
with a bacterium carrying NDM-1, occurring in a Belgian
man being repatriated in Belgium after a car accident during
a trip in Pakistan. Because this carbapenemase is encoded by
a genetic element found on different plasmids that may dupli-
cate or jump from bacteria to bacteria easily, rapid dissemi-
nation and spread between different bacterial species by
lateral gene transfer favoured by globalization and travel rep-
resent a high risk of a worldwide pandemia among Enterobac-
teriaceae. Moreover, the NDM-1 spread poses once again at
least four major problems frequently highlighted when deal-
ing with MBLs [1], namely: (i) the lack of a routine standard-
ized phenotypic test for MBL detection; (ii) the consequent
probable high prevalence of unrecognized asymptomatic car-
riers, allowing an international dissemination of such bacteria;
(iii) the scarcity of available effective antibiotics so far, and
(iv) the possibility to disseminate in many different Gram-
negative bacteria. Molecular methods, especially real-time
PCR, should be used for the detection of this speciﬁc carba-
penemase-encoding gene, especially for patients returning
from Asia, to limit the propagation and dissemination of
these alarming ‘superbugs’. A systematic monitoring of both
infected patients and possible asymptomatic carriers return-
ing from Asia should be the rule to implement control strat-
egy policies such as contact isolation procedures. However,
both the rapidly growing number of potential contacts to
isolate and the multiplicity of geographical areas at risk could
make this approach problematic, if not virtually impossible,
within a very short time.
In conclusion, the NDM-1 gene spreading in Enterobacteria-
ceae is an alarming risk because these novel multidrug-
resistant bacteria (increasingly familiar even to the lay public
as ‘superbugs’) could disseminate worldwide very quickly and
originate a wide and uncontrollable spread of pandemic
clones for which new and effective antibiotics are currently
not available.
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FIG. 1. Global spread of the New Delhi
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